MIER3 is a predominantly nuclear ELM2-SANT family protein implicated in transcriptional repression and the control of epithelial-mesenchymal transition (EMT) in cancer (PMID:28046085, PMID:28887525). Unlike its paralogs MIER1 and MIER2, MIER3 does not constitutively recruit HDAC1 or HDAC2 and its complexes carry no associated deacetylase activity in HEK293, MCF7, and HeLa cells, nor does it homodimerize or heterodimerize with other MIER family members (PMID:28046085). In a breast cancer context, MIER3 assembles a co-repressor complex with HDAC1, HDAC2, and Snail that binds the E-cadherin promoter and drives its histone-deacetylation-dependent silencing, promoting EMT (PMID:34242623). In colorectal cancer, MIER3 instead acts as a tumor suppressor, inhibiting proliferation, migration, invasion, and xenograft growth and metastasis through reduction of Sp1 protein levels and consequent suppression of EMT (PMID:28887525). In non-small-cell lung cancer, MIER3 overexpression suppresses proliferation and invasion, inhibits Wnt/β-catenin signaling, and decreases the histone acetyltransferase activity of p300 (PMID:35117188). The opposing co-repressor and tumor-suppressor roles reported across tissue contexts are not reconciled mechanistically in the available corpus.